
Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Bloo
Description
Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032
Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW:
Lyme disease is occurred due to a bacterial infection by borrelia species. This is spread through the bite of infected ticks in humans. The symptoms of Lyme disease in infected patients are fever, skin rashes, depression & fatigue. Early detection of the disease may be treated with antibiotics. By prolonging the disease without treating it, results in heart, joint and CNS disorders and might become fatal. The diagnostics intended to trat the lyme disease are called Lyme disease diagnostics.
MARKET HIGHLIGHTS
Global Lyme Disease Diagnostics Market is expected to project a CAGR of 6.8% during the forecast period, 2022-2032
Global Lyme Disease Diagnostics Market is expected to reach USD 3.7 billion, growing at a CAGR of 6.8% during forecast period. Increasing focus of governments towards well establishment of healthcare facilities, growing prevalence of Lyme disease and the emergence of new Lyme disease diagnostic tests are expected to drive the growth of the Global Lyme Disease Diagnostics market. Rising enthusiasm of key players towards Research & Development of Lyme disease diagnosis is expected to drive the growth of the market.
GLOBAL LYME DISEASE DIAGNOSTICS MARKET SEGMENTATION:
Serological Test Segment is expected to grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the Diagnostic Technology into Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and Others. Serological test segment is expected to dominate the market in the forecast period owing to the preference of this test to measures the antibodies in the later phase of illness after nucleic acid test and PCR test which are advantageous in assessing Lyme disease.
Hospital Segment is expected to grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the End User into Hospitals, Public/Private Laboratories, and Physicians Office. Hospital segment is expected to dominate the Lyme disease diagnostic market in the forecast period owing to the growing hospitals count with skilled professionals, availability of commercial diagnostic kits to identify Lyme disease easily and well-structured healthcare infrastructure which is expected to boost the market growth.
MARKET DYNAMICS:
Growth Drivers
Increasing Patient Population is Expected to Boost the Growth of the Market
Introduction of New Initiatives by the Government is Expected to Boost the Growth of the Market
Restraint
Lack of Disease Awareness May Hamper the Market Growth
GLOBAL LYME DISEASE DIAGNOSTICS MARKET
Key Players Covered:
- Bio-Rad Laboratories, Inc.
- Abbott
- Thermo Fisher Scientific, Inc.
- Oxford Immunotec Global PLC
- T2 Biosystems, Inc.
- Quidel Corporation
- Hoffmann-La Roche Ltd
- Graphene Frontiers
- Diasorin S.p.A
- Trinity Biotech
- Quest Diagnostics
- Other Prominent Player
Global Lyme Disease Diagnostics Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the Lyme disease diagnostics market in 2021 and is expected to dominate the same over the forecast period owing to the increasing government initiatives for diagnosing and treating of several diseases. The focus to develop new strategies in order to prevent Lyme disease has increased aiming to reduce occurrence of disease in population. The increment in pervasiveness of common tick disease, resulted in creating demand for disease treatment, thereby resulting in driving the growth of Lyme Disease Diagnostics Market.
- Reasons to Purchase this Report
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
249 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Lyme Disease Diagnostics Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2 Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3 Market Characteristics
- 3.1. Market Definition
- 3.2. Lyme Disease Diagnostics Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4 Lyme Disease Diagnostics Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5 Macroeconomic Indicators
- 6 Recent Developments
- 7 Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8 Risk Analysis
- 9 Market Analysis
- 9.1. Porters Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10 Lyme Disease Diagnostics Market
- 10.1. Overview
- 10.2. Historical Analysis (2016-2021)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11 Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Diagnostic Technology
- 11.3.1.1. Serological Test (ELISA, Western Blot)
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2. Market Share (%) 2022-2032F
- 11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2. Lymphocytic Transformation Test
- 11.3.1.2.1. By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3. Urine Antigen Testing
- 11.3.1.3.1. By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4. Immunofluorescent Staining
- 11.3.1.4.1. By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.5. Nucleic acid Test
- 11.3.1.5.1. By Value (USD Million) 2022-2032F
- 11.3.1.5.2. Market Share (%) 2022-2032F
- 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.6. Others
- 11.3.1.6.1. By Value (USD Million) 2022-2032F
- 11.3.1.6.2. Market Share (%) 2022-2032F
- 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Sample
- 11.3.2.1. Blood
- 11.3.2.1.1. By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Cerebrospinal Fluid
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2. Market Share (%) 2022-2032F
- 11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Joint Fluid
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2. Market Share (%) 2022-2032F
- 11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.4. Urine
- 11.3.2.4.1. By Value (USD Million) 2022-2032F
- 11.3.2.4.2. Market Share (%) 2022-2032F
- 11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By End User
- 11.3.3.1. Hospitals
- 11.3.3.1.1. By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Public/Private Laboratories
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2. Market Share (%) 2022-2032F
- 11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.3. Physician’s Office
- 11.3.3.3.1. By Value (USD Million) 2022-2032F
- 11.3.3.3.2. Market Share (%) 2022-2032F
- 11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
- 12 North America Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Diagnostic Technology
- 12.3.2. By Sample
- 12.3.3. By End User
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13 Europe Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Diagnostic Technology
- 13.3.2. By Sample
- 13.3.3. By End User
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14 Asia Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Diagnostic Technology
- 14.3.2. By Sample
- 14.3.3. By End User
- 14.4. Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15 Middle East and Africa Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Diagnostic Technology
- 15.3.2. By Sample
- 15.3.3. By End User
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16 Latin America Lyme Disease Diagnostics Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Diagnostic Technology
- 16.3.2. By Sample
- 16.3.3. By End User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17 Competitive Landscape
- 17.1. Company market share, 2021
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18 Company Profiles
- 18.1. Bio-Rad Laboratories, Inc.
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Abbott
- 18.3. Thermo Fisher Scientific, Inc.
- 18.4. Oxford Immunotec Global PLC
- 18.5. T2 Biosystems, Inc.
- 18.6. Quidel Corporation
- 18.7. Hoffmann-La Roche Ltd
- 18.8. Graphene Frontiers
- 18.9. Diasorin S.p.A
- 18.10. Trinity Biotech
- 18.11. Quest Diagnostics
- 18.12. Other Prominent Players
- 19 Appendix
- 20 Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.